Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and production method thereof

A technology for chronic fatigue and syndrome, which can be used in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., and can solve problems such as little involvement in prevention and treatment

Inactive Publication Date: 2013-07-10
南充市中心医院
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Epidemiological surveys show that there are more and more patients with chronic fatigue syndrome. Western medicine has not made breakthroughs in its treatment because the cause of the disease is not clear. Traditional Chinese medicine has a lot of research, but it is rarely used for prevention and treatment. At present, it has been marketed in China. There are few drugs and hospital preparations for the treatment of chronic fatigue syndrome, so the development of drugs for the prevention and treatment of chronic fatigue syndrome has important clinical significance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and production method thereof
  • Astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and production method thereof
  • Astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1, the present invention is formulated by following bulk drug components and weight ratio:

[0039] Astragalus 260 Donkey-hide gelatin 100 Codonopsis 280

[0040] Angelica 50 Hawthorn 43 Wolfberry 90

[0041] Polygonum multiflorum 90, jujube 200, Buddha's hand 130

[0042] Walnut kernel 175 black sesame 180 three seven 10 water 14470.

[0043] 2.4 parts by weight of sodium benzoate and 0.26 parts by weight of p-hydroxyphenylethyl ester can also be added as required.

[0044] The production method of product of the present invention is as follows:

[0045] 1. Prepare materials according to the above raw material components and weight ratio;

[0046] 2. Grind donkey-hide gelatin into coarse powder and Panax notoginseng into fine powder, set aside;

[0047] 3. Grind black sesame seeds and walnut kernels into coarse powder, add 8 times the amount of water to soak for 3 hours, then decoct three times, each decocting for 20 minutes, filter the decoction, and o...

Embodiment 2

[0052] Embodiment 2, the present invention is formulated by following bulk drug components and weight ratio:

[0053] Astragalus 300 Donkey-hide gelatin 87 Codonopsis 260

[0054] Angelica 50 Hawthorn 50 Wolfberry 87

[0055] Polygonum multiflorum 87, jujube 175, Buddha's hand 150

[0056] Walnut kernels 200 black sesame seeds 175 three seven 9 water 15674.

[0057] 2.6 parts by weight of sodium benzoate and 0.24 parts by weight of p-hydroxyphenylethyl ester can also be added as required.

[0058] The production method of product of the present invention is as follows:

[0059] 1. Prepare materials according to the above raw material components and weight ratio;

[0060] 2. Grind donkey-hide gelatin into coarse powder and Panax notoginseng into fine powder, set aside;

[0061] 3. Grind black sesame seeds and walnut kernels into coarse powder, add 8 times the amount of water to soak for 3 hours, then decoct three times, each decocting for 20 minutes, filter the decoction, ...

Embodiment 3

[0066] Embodiment 3, the present invention is formulated by following bulk drug component and weight ratio:

[0067] Astragalus 280 Donkey-hide gelatin 90 Codonopsis 300

[0068] Angelica 45 Hawthorn 47 Wolfberry 100

[0069] Polygonum multiflorum 100, jujube 180, Buddha's hand 140

[0070] Walnut 180 black sesame 200 three seven 9.5 water 15140.

[0071] 2.5 parts by weight of sodium benzoate and 0.25 parts by weight of p-hydroxyphenethyl can also be added as required.

[0072] The production method of product of the present invention is as follows:

[0073] 1. Prepare materials according to the above raw material components and weight ratio;

[0074] 2. Grind donkey-hide gelatin into coarse powder and Panax notoginseng into fine powder, set aside;

[0075] 3. Grind black sesame seeds and walnut kernels into coarse powder, add 8 times the amount of water to soak for 3 hours, then decoct three times, each decocting for 20 minutes, filter the decoction, and obtain filtrate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and a production method thereof. The astragalus mongholicus and donkey-hide gelatin paste is characterized by being prepared from the following bulk pharmaceutical chemicals in weight ratio: astragalus mongholicus 260-300, donkey-hide gelatin 87-100, codonopsis pilosula 260-300, angelica 43-50, hawthorn 43-50, Chinese wolfberry 87-100, radix polygoni multifori preparata 87-100, Chinese date 175-200, citrus chirocarpus 130-150, walnut kernel 175-200, black sesame seed 175-200, pseudo-ginseng 9-10 and water 13824-15900. After one, two and three periods of treatment, the results show that the total efficiencies of a treatment group are respectively 83.87%, 93.55% and 96.77%.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a gelatin ointment for treating chronic fatigue syndrome and a production method thereof. Background technique [0002] With the acceleration of the pace of society and life, the number of patients with chronic fatigue syndrome (Chronic Fatigue Syndrome, referred to as CFS) is increasing. Japan is one of the regions with the highest incidence rate, with an average of 1.5%. The incidence rate in the United States is 0.1% to 0.2%, and the incidence rate in the United Kingdom is 0.56%. According to the survey in some parts of northern my country, the prevalence rate was 1.95%. The incidence rate of CFS is higher among scientific and technical personnel, accounting for 26.23%, followed by college students and cadres with 18.31% and 17.32% respectively. In primary primary medical units, the prevalence of CFS was 2.6%. 37% of CFS patients are unable to work. CFS has become a public h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/815A61P39/00A61K35/36
Inventor 张燕何进樊幼林黄梅
Owner 南充市中心医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com